Lp(a) shows promise as a CAD screening biomarker 

Lp(a) could be a useful screening biomarker to identify vulnerable patients with coronary artery disease (CAD) who are currently underdiagnosed, such as those without modifiable cardiovascular risk factors, suggest cardiology researchers.